BOLT vs NVDA · rev $7.7M vs P/E 58, rev $96.22B
Bolt Biotherapeutics (BOLT) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
BOLT currently screens at market cap $11.3M. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the BOLT and NVDA stock pages for the full models.
Not investment advice.